glutamine has been researched along with Ewing Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caplen, NJ; Cross, AM; Gryder, BE; Khan, J; Kim, S; Lorenzi, PL; Sen, N | 1 |
| Freeman, KW; Mary-Sinclair, MN; Olsen, RR; Yin, Z | 1 |
2 other study(ies) available for glutamine and Ewing Sarcoma
| Article | Year |
|---|---|
EWS-FLI1 reprograms the metabolism of Ewing sarcoma cells via positive regulation of glutamine import and serine-glycine biosynthesis.
Topics: Amino Acid Transport System ASC; Aminohydrolases; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Formate-Tetrahydrofolate Ligase; Gene Expression Regulation, Neoplastic; Glutamine; Glycine; HCT116 Cells; HEK293 Cells; Humans; Methylenetetrahydrofolate Dehydrogenase (NADP); Minor Histocompatibility Antigens; Multienzyme Complexes; Multifunctional Enzymes; Oncogene Proteins, Fusion; Phosphoglycerate Dehydrogenase; Proto-Oncogene Protein c-fli-1; RNA-Binding Protein EWS; Sarcoma, Ewing; Serine | 2018 |
Antagonizing Bcl-2 family members sensitizes neuroblastoma and Ewing's sarcoma to an inhibitor of glutamine metabolism.
Topics: Aniline Compounds; Animals; Antimetabolites, Antineoplastic; Apoptosis; Bone Neoplasms; Caspases; Cell Line, Tumor; Cell Proliferation; Diazooxonorleucine; Drug Synergism; Glutamine; Humans; Mice; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Sarcoma, Ewing; Sulfonamides; Xenograft Model Antitumor Assays | 2015 |